Kuros Biosciences Ltd CSBTF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $22.00
- Day Range
- $24.00–24.00
- 52-Week Range
- $22.00–42.81
- Bid/Ask
- $19.80 / $23.11
- Shares Outstanding
- 39.67M
- Market Cap
- $945.89M
- Volume/Avg
- 1,045 / 2,423
Key Statistics
- Price/Earnings (Normalized)
- 67.05
- Price/Sales
- 5.66
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Kuros Biosciences Ltd is a Swiss-based biotech company, focused on developing and commercializing biologic bone graft technologies for musculoskeletal applications, particularly in spine, trauma, extremities, and oncology. It has two reportable segments: i) Medical Devices: This segment includes products such as MagnetOs and Attrax, which are biphasic calcium phosphate (BCP) bone grafts that mimic the porous, trabecular structure of cancellous bone. ii) Legacy Portfolio: This segment includes all non-core products (including Checkmate licensing) that are outside the Group's primary therapeutic focus. The majority of the company's revenue is derived from the Medical Devices segment. Geographically, it generates the maximum revenue from the United States of America.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 213
- Website
- https://www.kurosbio.com
Valuation
|
Metric
|
CSBTF
|
|---|---|
Price/Earnings (Normalized) | 67.05 |
Price/Book Value | 10.60 |
Price/Sales | 5.66 |
Price/Cash Flow | 60.33 |
Price/Earnings
CSBTF
Financial Strength
|
Metric
|
CSBTF
|
|---|---|
Quick Ratio | 1.22 |
Current Ratio | 1.87 |
Interest Coverage | — |
Quick Ratio
CSBTF
Profitability
|
Metric
|
CSBTF
|
|---|---|
Return on Assets (Normalized) | 6.80% |
Return on Equity (Normalized) | 10.67% |
Return on Invested Capital (Normalized) | 6.55% |
Return on Assets
CSBTF
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|Z%$HsZ@ | LOCK|NlZM# | $178B | |||
| Medtronic PLC
MDT
| LOCK|Qq?vy#^ | LOCK|j!njm | $121B | |||
| Stryker Corp
SYK
| LOCK|ZDc@!<C | LOCK|KZ | $108B | |||
| Boston Scientific Corp
BSX
| LOCK|S&@lDn^ | LOCK|?Lt$? | $62B | |||
| Edwards Lifesciences Corp
EW
| LOCK|&<Y>VL#g | LOCK|@R#z | $50B | |||
| DexCom Inc
DXCM
| LOCK|sbg>#?% | LOCK|Nf@q | $31B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|$Dl@G% | LOCK|f$F | $31B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|g&v | LOCK|Lbm | $25B | |||
| Steris PLC
STE
| LOCK|db>>x&@ | LOCK|Xxqk | $21B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|^>dyhj$ | LOCK|@Wp | $18B |
United States